Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major ...

Sugammadex (Bridion; Merck) is a small-molecule oligosaccharide, also known as a modified gamma cyclodextin, that was approved by the FDA in 2015 to reverse the anesthesia-induced neuromuscular ...

Treatments for myasthenia gravis include steroids to suppress the immune system, plasmapheresis to counteract the autoimmune process, Mestinon, Regonol (pyridostigmine), which is an anticholinesterase ...